Literature DB >> 814165

The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1.

D Yasmeen, J R Ellerson, K J Dorrington, R H Painter.   

Abstract

The fragments related to the Cgamma2 and Cgamma3 homology regions of human IgG, described in the preceding paper by Ellerson, et al. were assayed for their ability to interact with complement, engage in cytophilic activity toward macrophages, and to play a role in controlling the catabolism of the whole IgG. The Cgamma2-fragment retained about 3% of the activity of intact IgG in a whole complement-fixing assay in which the test proteins were absorbed as mono-layers onto polystyrene latex beads. However, in a fluid-phase C1-binding assay this fragment showed the same activity as IgG and Fc fragment, when compared on a molar basis. Since the Cgamma2-fragment represented only one intact domain, full expression of complement-fixing activity appeared to be independent of quaternary interactions. Thus IgG possesses two C1-binding sites. The Cgamma3-fragment was inactive in both of the complement assays. The ability of IgG to interact with the Fc-receptor on guinea-pig macrophages was shown to be entirely a function of the Cgamma3 region. This was demonstrated both in a direct assay in which tanned red cells coated with Cgamma3-fragment formed rosettes with macrophages and in an indirect assay in which this fragment was able to inhibit rosette formation between IgG-coated red cells and macrophages. The rate of clearance of radiolabeled Cgamma2-, Cgamma3-, Fab, Fc fragments, and IgG from the circulation was measured in rabbits. The Cgamma2 fragment was cleared with a half-time similar to that shown by intact IgG and Fc (about 70 hr) whereas Cgamma3- and Fab fragments were cleared more rapidly (half-time, about 15 hr). The rate of cleaance was not related to the presence of sialic acid or exposed galactosyl residues at the termini of the carbohydrate prosthetic groups. These data clearly show that at least three of the biologic functions of IgG are mediated fully and independently by one or other of the Fc domains.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 814165

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Treatment of passively transferred experimental autoimmune myasthenia gravis using papain.

Authors:  K Poulas; T Tsouloufis; S J Tzartos
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.

Authors:  L K Tan; R J Shopes; V T Oi; S L Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

Authors:  Rui Gong; Yanping Wang; Yang Feng; Qi Zhao; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

4.  Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2.

Authors:  B M Mueller; R A Reisfeld; S D Gillies
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Purification and characterization of subcomponent C1q of the first component of bovine complement.

Authors:  R D Campbell; N A Booth; J E Fothergill
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

6.  Studies on the structural and biological functions of the Cmu4 domains of IgM.

Authors:  M O Bubb; J D Conradie
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

7.  Three-dimensional structure of a human immunoglobulin with a hinge deletion.

Authors:  L W Guddat; J N Herron; A B Edmundson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  The purification and characterization of subcomponent C1s of the first component of bovine complement.

Authors:  R D Campbell; N A Booth; J E Fothergill
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

9.  [Problems of intravenous gammaglobulin therapy (author's transl)].

Authors:  J Ring; K H Duswald
Journal:  Klin Wochenschr       Date:  1980-08-15

10.  The localization of the binding site(s) on human IgG1 for the Fc receptors on homologous monocytes and heterologous mouse macrophages.

Authors:  A Ratcliffe; D R Stanworth
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.